I've heard of the major things you should do like looking at a company's pipeline, looking at their potential market, fundamentals, insider activity and revenue/debt, reading their papers 2-3 weeks out from a catalyst date, looking at what biochemical pathway their drug utilizes and how it compares to similar ones, etc. but what other specifics do you do before buying into one?
Disclaimer: I have a background in science. I'm fully aware of and willing to accept the high risk biotechs have and plan on only investing a tiny part of my portfolio in them.
Submitted December 02, 2018 at 12:05PM by Headkickerchamp https://ift.tt/2AHIU2s
